LU84892A1 - Komposition zur reduktion der sebumsekretion - Google Patents

Komposition zur reduktion der sebumsekretion Download PDF

Info

Publication number
LU84892A1
LU84892A1 LU84892A LU84892A LU84892A1 LU 84892 A1 LU84892 A1 LU 84892A1 LU 84892 A LU84892 A LU 84892A LU 84892 A LU84892 A LU 84892A LU 84892 A1 LU84892 A1 LU 84892A1
Authority
LU
Luxembourg
Prior art keywords
compound
sebum
tetramethyl
preparation according
tetrahydro
Prior art date
Application number
LU84892A
Other languages
German (de)
English (en)
French (fr)
Inventor
Alfred Boris
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of LU84892A1 publication Critical patent/LU84892A1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/32—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
    • C07C13/47—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with a bicyclo ring system containing ten carbon atoms
    • C07C13/48—Completely or partially hydrogenated naphthalenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Dental Preparations (AREA)
LU84892A 1982-07-02 1983-06-30 Komposition zur reduktion der sebumsekretion LU84892A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39475482A 1982-07-02 1982-07-02
US39475482 1982-07-02

Publications (1)

Publication Number Publication Date
LU84892A1 true LU84892A1 (fr) 1985-03-29

Family

ID=23560291

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84892A LU84892A1 (fr) 1982-07-02 1983-06-30 Komposition zur reduktion der sebumsekretion

Country Status (30)

Country Link
US (1) US4588750A (sv)
JP (1) JPS5921630A (sv)
KR (1) KR840005341A (sv)
AR (1) AR230180A1 (sv)
AU (1) AU565242B2 (sv)
BE (1) BE897195A (sv)
BR (1) BR8303529A (sv)
CA (1) CA1221032A (sv)
CH (1) CH654287A5 (sv)
DE (1) DE3323585A1 (sv)
DK (1) DK291583A (sv)
DO (1) DOP1983004277A (sv)
ES (1) ES8700049A1 (sv)
FI (1) FI832432L (sv)
FR (1) FR2529458B1 (sv)
GB (1) GB2123692B (sv)
GR (1) GR79328B (sv)
IE (1) IE55206B1 (sv)
IL (1) IL69118A (sv)
IT (1) IT1169742B (sv)
LU (1) LU84892A1 (sv)
MC (1) MC1525A1 (sv)
NL (1) NL8302346A (sv)
NO (1) NO832417L (sv)
NZ (1) NZ204767A (sv)
PH (1) PH19249A (sv)
PT (1) PT76974B (sv)
SE (1) SE453636B (sv)
ZA (1) ZA834804B (sv)
ZW (1) ZW15183A1 (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110801A (en) * 1984-08-13 1992-05-05 Leveen Harry H Treatment of acne
CA1268124A (en) * 1985-06-28 1990-04-24 Werner Bollag Use of a retinoid
CA1268125A (en) * 1985-06-28 1990-04-24 F. Hoffmann-La Roche Ag Use of a retinoid
US5030764A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US5030765A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
ZW7487A1 (en) * 1986-05-23 1987-12-16 Hoffmann La Roche Tetrahydronaphthaline and indane derivatives
AT388728B (de) * 1987-03-17 1989-08-25 Hoffmann La Roche Neue tetrahydronaphthalin- und indanderivate
DE3903989A1 (de) * 1989-02-10 1990-09-20 Basf Ag Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
DE3903990A1 (de) * 1989-02-10 1990-08-30 Basf Ag Phenylhydrazone, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
DE3903988A1 (de) * 1989-02-10 1990-08-30 Basf Ag Oxidierte diphenylheteroalkane, ihre herstellung und verwendung
DE3903991A1 (de) * 1989-02-10 1990-08-30 Basf Ag Phenylhydrazone des (beta)-jonons, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
GB9315156D0 (en) * 1993-07-22 1993-09-08 Ici Plc Coating compositions
DE10016625A1 (de) 2000-04-04 2001-10-11 Basell Polyolefine Gmbh Gasphasenpolymerisationsverfahren mit Direktkühlsystem
US20040009138A1 (en) * 2002-05-20 2004-01-15 Kling William O. Skin cleanser compositions and methods of use
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
US20050180940A1 (en) * 2004-02-17 2005-08-18 Puma Jeffrey P. Protect against hair loss

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060228A1 (de) * 1970-12-08 1972-06-15 Hoechst Ag Monostyryl-naphthalin-Derivate,Verfahren zu deren Herstellung und ihre Verwendung als optische Aufhellungsmittel
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
DK159967C (da) * 1977-12-22 1991-06-03 Hoffmann La Roche Analogifremgangsmaade til fremstilling af terapeutisk aktive stilbenderivater

Also Published As

Publication number Publication date
FI832432L (fi) 1984-01-03
DE3323585A1 (de) 1984-01-05
FR2529458B1 (fr) 1986-10-24
SE8303732D0 (sv) 1983-06-30
ES8700049A1 (es) 1986-10-16
GB2123692B (en) 1986-07-09
IT1169742B (it) 1987-06-03
FI832432A0 (fi) 1983-07-01
IL69118A0 (en) 1983-10-31
IT8321896A0 (it) 1983-07-01
SE453636B (sv) 1988-02-22
PT76974B (en) 1986-06-26
MC1525A1 (fr) 1984-04-13
DK291583D0 (da) 1983-06-23
BE897195A (fr) 1984-01-02
AR230180A1 (es) 1984-03-01
ES523760A0 (es) 1986-10-16
IE831548L (en) 1984-01-02
SE8303732L (sv) 1984-01-03
CH654287A5 (de) 1986-02-14
DOP1983004277A (es) 1990-03-20
PH19249A (en) 1986-02-14
NL8302346A (nl) 1984-02-01
CA1221032A (en) 1987-04-28
GB8317991D0 (en) 1983-08-03
AU565242B2 (en) 1987-09-10
BR8303529A (pt) 1984-02-07
NZ204767A (en) 1986-06-11
ZA834804B (en) 1984-03-28
IE55206B1 (en) 1990-07-04
GB2123692A (en) 1984-02-08
FR2529458A1 (fr) 1984-01-06
US4588750A (en) 1986-05-13
AU1646583A (en) 1984-01-05
KR840005341A (ko) 1984-11-12
DK291583A (da) 1984-01-03
NO832417L (no) 1984-01-03
GR79328B (sv) 1984-10-22
JPS5921630A (ja) 1984-02-03
ZW15183A1 (en) 1985-01-23
PT76974A (en) 1983-08-01
IL69118A (en) 1986-07-31

Similar Documents

Publication Publication Date Title
DE69821624T2 (de) 9-cis-RETINSÄURE FÜR ZELLVERMITTELTE IMMUNKRANKHEITEN
DE3690187C2 (de) Naphthalinderivate mit retinoider Wirkung, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische und kosmetische Mittel
DE2818553A1 (de) Zusammensetzung zur behandlung von proliferativen hautkrankheiten
DE3205504C2 (de) Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel
LU84892A1 (fr) Komposition zur reduktion der sebumsekretion
DE2721831A1 (de) Entzuendungshemmende, topisch anzuwendende arzneipraeparate
DE4133694A1 (de) Verwendung einer emulsion, zur herstellung eines arzneimittels zur i.v.-verabreichung zur behandlung von hauterkrankungen
EP0241809A1 (de) Synergistische Kombination von Amantadin und Selegilin
DE2128462C2 (de) Arzneimittel auf Basis von Vitamin-A-Säure-Isomeren
US3934028A (en) Acne and psoriasis treatment with retinoic acid analogs
DE60004786T2 (de) Verfahren und zusammensetzung zur behandlung von akne
US4021573A (en) Psoriasis treatment with retinoic acid analogs
DE60132008T2 (de) Cetylmyristat und cetylpalmitat zur behandlung von ekzemen und/oder psoriasis
DE4330664A1 (de) Verwendungen von Pflanzenölen
US4007268A (en) Process for alleviating proliferative skin diseases
DE60110897T2 (de) Der duale inhibitor der cholesterylester und wachsester synthese avasimibe zur behandlung von erkrankungen des talgdrüse
EP0010208B1 (de) Pharmazeutisches Mittel, enthaltend all-E- oder 13-Z-7,8-Dehydro-Retinsäure und Verfahren zu seiner Herstellung
EP0996438B1 (de) Verwendung von estern der cis-6-hexadecensäure zur behandlung von psoriasis, allergien und autoimmunerkrankungen sowie bei trockener und empfindlicher haut
DE1667903C3 (de) Verwendung von Cysteinderivaten zur Herstellung von per oral verabreichbaren Mitteln zur Bekämpfung der Seborrhoe
DE3116029A1 (de) 3-deazaadenosin als entzuendungshemmendes mittel
DE2318784A1 (de) N-(2,4-dihydroxybenzoyl)-4-aminosalizylsaeure
DE3306299C2 (sv)
DE10156617A1 (de) Herstellung reiner Stereoisomere von Tricyclo[5.2.1.0··2··.··6··]-dec-9-yl-xanthogenat und Arzneimittel daraus
EP0207421B1 (de) Verwendung eines Retinoids zur Herstellung eines antikeratinisierenden Arzneimittels
DE2843884A1 (de) Mittel, enthaltend 2-(retinyliden)- malonsaeurederivate